GGrantIndex
Sort

326,823 grants matching clinical trial

Flavivirus Infections: Pathogenesis and Prevention

$2,094,472
Alan L Rothman · University Of Rhode Island · P01 · FY2011 · AI

ADULT THERAPEUTIC CLINICAL TRIALS PROGRAM FOR AIDS

$2,094,303
University Of North Carolina Chapel Hill · U01 · FY2002 · AI

MU-JHU HPTU TRIAL SITE - UGANDA

$2,094,277
Johns Hopkins University · U01 · FY2001 · AI

Trial to Reduce IDDM in the Genetically at Risk -study

$2,094,226
Mikael Knip · University Of Helsinki · U01 · FY2013 · HD

IMMUNITY TO MELANOMA VIA DENDRITIC CELLS

$2,094,162
Baylor Research Institute · P01 · FY2001 · CA

Vanderbilt Center for Undiagnosed Diseases (VCUD)

$2,094,080
John Atlas Phillips III · Vanderbilt University Medical Center · U01 · FY2016 · HG

Mayo Clinic Ovarian Cancer SPORE

$2,093,975
Scott H Kaufmann · Mayo Clinic Rochester · P50 · FY2025 · CA

MSK SPORE in Lymphoma

$2,093,966
Andrew D. Zelenetz · Sloan-Kettering Inst Can Research · P50 · FY2019 · CA

The Pacific Northwest Prostate Cancer SPORE

$2,093,934
Peter S Nelson · Fred Hutchinson Cancer Research Center · P50 · FY2019 · CA

BIOLOGY OF HEMATOPOIETIC STEM CELLS

$2,093,885
Fred Hutchinson Cancer Research Center · P50 · FY2000 · HL

A Chemical Biology Network for Personalized Medicine

$2,093,862
Timothy J Cardozo · New York University School Of Medicine · RC2 · FY2010 · LM

The University of Texas M. D. Anderson Cancer Center SPORE in Ovarian Cancer

$2,093,826
Robert C Bast · University Of Tx Md Anderson Can Ctr · P50 · FY2014 · CA

ADULT AIDS CLINICAL TRIALS UNIT (AACTU)

$2,093,817
University Of Rochester · U01 · FY2001 · AI

Chicago Clinical Trials Unit

$2,093,731
Babafemi O Taiwo · Northwestern University At Chicago · UM1 · FY2019 · AI

Task V06: Process development and manufacture of cGMP compliant parvovirus B19 vaccine drug product for use in Phase I/II clinical trials

$2,093,700
Timothy Fouts · Advanced Bioscience Laboratories, Inc. · N01 · FY2019 · AI

Completion of Non-clinical long-term GLP safety and GMP manufacture for first-in-class neuron regenerative therapy, NNI-362 Phase 2 POC AD trial

$2,093,556
Judith A Kelleher-Andersson · Neuronascent, Inc. · U01 · FY2024 · AG

Vanderbilt Center for Undiagnosed Diseases (VCUD)

$2,093,452
John Atlas Phillips III · Vanderbilt University Medical Center · U01 · FY2017 · HG

Cancer Therapy & Research Center at UTHSCSA

$2,093,000
Ruben A Mesa · University Of Texas Hlth Science Center · P30 · FY2017 · CA

Medical University of South Carolina - Cancer Center Support Grant

$2,093,000
Gustavo Walter Leone · Medical University Of South Carolina · P30 · FY2017 · CA

Cancer Therapy & Research Center at UTHSCSA

$2,093,000
Ruben A Mesa · University Of Texas Hlth Science Center · P30 · FY2018 · CA

Cancer Therapy & Research Center at UTHSCSA

$2,093,000
Tim H.-M. Huang · University Of Texas Hlth Science Center · P30 · FY2016 · CA

Medical University of South Carolina - Cancer Center Support Grant

$2,093,000
Gustavo Walter Leone · Medical University Of South Carolina · P30 · FY2018 · CA

Medical University of South Carolina - Cancer Center Support Grant

$2,093,000
Anthony J Alberg · Medical University Of South Carolina · P30 · FY2016 · CA

Integrated heart-liver-vascular systems for drug testing in human health and dise

$2,092,852
Gordana Vunjak-Novakovic · Columbia University Health Sciences · UH3 · FY2015 · EB

Translational Research in Breast Cancer

$2,092,818
Xiang Zhang · Baylor College Of Medicine · P50 · FY2021 · CA